ANGPTL3 and metabolic syndrome: Due to their role in regulating plasma lipid content and nutrient sensing, therapeutic modulation of the activity of ANGPTL3, 4 and 8 is currently under considerable investigation as potential targets in the treatment of dyslipidemia [7–9].